SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001123292-24-000113
Filing Date
2024-04-18
Accepted
2024-04-18 16:18:42
Documents
1
Group Members
BLUE HORIZON ENTERPRISE LTDEZBON INTERNATIONAL LTDMONTRAGO TRUSTEES LTD

Document Format Files

Seq Description Document Type Size
1 stoke13d.htm SC 13D/A 175812
  Complete submission text file 0001123292-24-000113.txt   177609
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Subject) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91051 | Film No.: 24854522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 195 ARCH. MAKARIOS III AVE. NEOCLEOUS HOUSE LIMASSOL G4 3030
Business Address 195 ARCH. MAKARIOS III AVE. NEOCLEOUS HOUSE LIMASSOL G4 3030 3-572-511-0165
Skorpios Trust (Filed by) CIK: 0001869333 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G4 | Fiscal Year End: 1231
Type: SC 13D/A